STOCK TITAN

TELA Bio to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TELA Bio, Inc. is preparing to participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1-3, 2020. The company specializes in medical technology, developing innovative tissue reinforcement materials for soft tissue reconstruction. Their products aim to address gaps in existing biologics and reduce the long-term risks of permanent synthetic materials. Interested parties can access the fireside chat presentation link through TELA's investor relations page.

Positive
  • None.
Negative
  • None.

MALVERN, Pa., Nov. 24, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference.

Conference Dates: Tuesday, December 1 to Thursday, December 3, 2020.
A link to the fireside chat presentation is available on the "Investors" section of the Company's website at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio, Inc. is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. TELA's products are designed to improve on shortcomings of existing biologics and minimize long-term exposure to permanent synthetic material. TELA's portfolio is supported by quality, data-driven science and extensive pre-clinical research that has consistently demonstrated advantages over other commercially available products.

TELA Bio Contact
Stuart Henderson
Vice President, Corporate Development and Investor Relations
TELA Bio, Inc.
484-320-2930

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com


FAQ

What is TELA Bio's participation in the Piper Sandler Conference?

TELA Bio will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1-3, 2020.

Where can I find TELA Bio's conference presentation link?

The link to TELA Bio's fireside chat presentation is available on the Investors section of their website.

What does TELA Bio focus on in medical technology?

TELA Bio focuses on designing and marketing tissue reinforcement materials for soft tissue reconstruction.

What are the dates of the Piper Sandler Conference?

The Piper Sandler 32nd Annual Virtual Healthcare Conference is scheduled for December 1-3, 2020.

What innovative solutions does TELA Bio provide?

TELA Bio's products are designed to improve existing biologics and minimize risks associated with permanent synthetic materials.

TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

113.18M
33.31M
7.32%
51.7%
0.85%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN